Advertisement

Ads Placeholder
Loading...

Elanco Animal Health Incorporated

ELANNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$23.08
$-0.04(-0.17%)
U.S. Market opens in 0h 44m

Elanco Animal Health Incorporated (ELAN) Stock Overview

Explore Elanco Animal Health Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.5B
P/E Ratio-49.43
EPS (TTM)$-0.47
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$23.99
3 Months$30.26
1 Year Target$30.54

ELAN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Elanco Animal Health Incorporated (ELAN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $30.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -49.43 and a market capitalization of 11.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.17%
5-Day Change
-6.37%
1-Month Change
-7.23%
3-Month Change
2.49%
6-Month Change
11.82%
Year-to-Date (YTD) Change
2.49%
1-Year Change
137.45%
3-Year Change
149.51%
5-Year Change
-20.30%
All-Time (Max) Change
-35.89%

Contact Information

877 352 6261
2500 Innovation Way, Greenfield, IN, 46140

Company Facts

90,000 Employees
IPO DateSep 20, 2018
CountryUS
Actively Trading

Frequently Asked Questions